Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice

European Journal of Pharmacology

Volumn 588, Issue 1, 2008, Pages 52-57

  Haddad, Marianne ^a   Beray Berthat, Virginie ^a   Coqueran, Bérard ^a   Palmier, Bruno ^a   Szabo, Csaba ^b   Plotkine, Michel ^a   Margaill, Isabelle ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

Cerebral hemorrhage; Matrix metalloproteinase; PARP (poly(ADP ribose)polymerase); PJ34; Stroke

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MICROSCOPY; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; ZYMOGRAPHY;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; ENZYME INHIBITORS; MALE; METALLOPROTEASES; MICE; MOTOR ACTIVITY; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES; PSYCHOMOTOR PERFORMANCE;

EID: 44249095059     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.013     Document Type: Article

References (43)

1. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., and Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21 (2001) 7724-7732
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
3. Chiarugi A. Poly(ADP-ribosyl)ation and stroke. Pharmacol. Res. 52 (2005) 15-24
4. Clark A.W., Krekoski C.A., Bou S.S., Chapman K.R., and Edwards D.R. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci. Lett. 238 (1997) 53-56
5. Couturier J.Y., Ding-Zhou L., Croci N., Plotkine M., and Margaill I. 3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice. Exp. Neurol. 184 (2003) 973-980
6. Crome O., Doeppner T.R., Schwarting S., Müller B., Bähr M., and Weise J. Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo. J. Neurosci. Res. 85 (2007) 1734-1743
7. Del Zoppo G.J., and Mabuchi T. Cerebral microvessel responses to focal ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 879-894
8. Endres M., Wang Z.Q., Namura S., Waeber C., and Moskowitz M.A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17 (1997) 1143-1151
9. Gidday J.M., Gasche Y.G., Copin J.C., Shah A.R., Perez R.S., Shapiro S.D., Chan P.H., and Park T.S. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H558-H568
10. Golanov E.V., and Reis D.J. Contribution of cerebral edema to the neuronal salvage elicited by stimulation of cerebellar fastigial nucleus after occlusion of the middle cerebral artery in rat. J. Cereb. Blood Flow Metab. 15 (1995) 172-174
11. Ha H.C., Hester L.D., and Snyder S.H. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3270-3275
12. Haddad M., Rhinn H., Bloquel C., Coqueran B., Szabo C., Plotkine M., Scherman D., and Margaill I. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br. J. Pharmacol. 149 (2006) 23-30
13. Hamann G.F., Okada Y., and del Zoppo G.J. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J. Cereb. Blood Flow Metab. 16 (1996) 1373-1378
14. Hamby A.M., Suh S.W., Kauppinen T.M., and Swanson R.A. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion. Stroke 38 (2007) 632-636
15. Hassa P.O., and Hottiger M.O. A role of poly (ADP-ribose) polymerase in NF-kappaB transcriptional activation. Biol. Chem. 380 (1999) 953-959
16. Heo J.H., Lucero J., Abumiya T., Koziol J.A., Copeland B.R., and del Zoppo G.J. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19 (1999) 624-633
17. Hornig C.R., Bauer T., Simon C., Trittmacher S., and Dorndorf W. Hemorrhagic transformation in cardioembolic cerebral infarction. Stroke 24 (1993) 465-468
18. Iwashita A., Tojo N., Matsuuara S., Yamasaki S., Kamijo K., Ishida J., Yamamoto H., Hattori K., Matsuoka N., and Mutoh S. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J. Pharmacol. Exp. Ther. 310 (2004) 425-436
19. Kauppinen T.M., and Swanson R.A. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J. Immunol. 174 (2005) 2288-2296
20. Kofler J., Otsuka T., Zhang Z., Noppens R., Grafe M.R., Koh D.W., Dawson V.L., de Murcia J.M., Hurn P.D., and Traystman R.J. Differential effect of PARP-2 deletion on brain injury after focal and global cerebral ischemia. J. Cereb. Blood Flow Metab. 26 (2006) 135-141
21. Koh S.H., Chang D.I., Kim H.T., Kim J., Kim M.H., Kim K.S., Bae I., Kim H., Kim D.W., and Kim S.H. Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model. Toxicology 214 (2005) 131-139
22. Leinhase I., Schmidt O.I., Thurman J.M., Hossini A.M., Rozanski M., Taha M.E., Scheffler A., John T., Smith W.R., Holers V.M., and Stahel P.F. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. Exp. Neurol. 199 (2006) 454-464
23. Lenzser G., Kis B., Snipes J.A., Gaspar T., Sandor P., Komjati K., Szabo C., and Busija D.W. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. J. Cereb. Blood Flow Metab. 27 (2007) 1318-1326
24. Lyden P.D., and Zivin J.A. Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc. Brain Metab. Rev. 5 (1993) 1-16
25. Montaner J., Alvarez-Sabin J., Molina C.A., Angles A., Abilleira S., Arenillas J., and Monasterio J. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 32 (2001) 2762-2767
26. Mun-Bryce S., and Rosenberg G.A. Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18 (1998) 1163-1172
27. Nguewa P.A., Fuertes M.A., Valladares B., Alonso C., and Perez J.M. Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications. Prog. Biophys. Mol. Biol. 88 (2005) 143-172
28. Okada Y., Yamaguchi T., Minematsu K., Miyashita T., Sawada T., Sadoshima S., Fujishima M., and Omae T. Hemorrhagic transformation in cerebral embolism. Stroke 20 (1989) 598-603
29. Paxinos G., and Franklin K. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, San Diego
30. Planas A.M., Sole S., and Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol. Dis. 8 (2001) 834-846
31. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., and Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29 (1998) 1020-1030
32. Rosell A., Ortega-Aznar A., Alvarez-Sabin J., Fernandez-Cadenas I., Ribo M., Molina C.A., Lo E.H., and Montaner J. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 37 (2006) 1399-1406
33. Rosenberg G.A., and Navratil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48 (1997) 921-926
34. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
35. Rosenberg G.A., Cunningham L.A., Wallace J., Alexander S., Estrada E.Y., Grossetete M., Razhagi A., Miller K., and Gearing A. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893 (2001) 104-112
36. Sumii T., and Lo E.H. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33 (2002) 831-836
37. Takahashi K., Pieper A.A., Croul S.E., Zhang J., Snyder S.H., and Greenberg J.H. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res. 829 (1999) 46-54
38. Tejima E., Zhao B.Q., Tsuji K., Rosell A., van Leyen K., Gonzalez R.G., Montaner J., Wang X., and Lo E.H. Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. J. Cereb. Blood Flow Metab. 27 (2007) 460-468
39. Wang J., and Tsirka S.E. Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain 128 (2005) 1622-1633
40. Yang Y., Estrada E.Y., Thompson J.F., Liu W., and Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27 (2007) 697-709
41. Yu S.W., Wang H., Dawson T.M., and Dawson V.L. Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol. Dis. 14 (2003) 303-317
42. Zhang J.W., and Gottschall P.E. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J. Neurosci. Methods 76 (1997) 15-20
43. Zhang L., Zhang Z.G., Zhang R.L., Lu M., Krams M., and Chopp M. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke 34 (2003) 1790-1795